Moreover, CD4+ T cells also display delayed cytotoxic activity: tumor cells directly presenting with MHC-II antigen can recruit CD4+ T cells, which can both kill the cancer cells and enhance the anti-tumor response of CD8+ T cells by secreting IFNγ and TNFα.90–93. The gene discussed is CD4; the disease is neoplasm.